JP2023506838A5 - - Google Patents
Info
- Publication number
- JP2023506838A5 JP2023506838A5 JP2022536658A JP2022536658A JP2023506838A5 JP 2023506838 A5 JP2023506838 A5 JP 2023506838A5 JP 2022536658 A JP2022536658 A JP 2022536658A JP 2022536658 A JP2022536658 A JP 2022536658A JP 2023506838 A5 JP2023506838 A5 JP 2023506838A5
- Authority
- JP
- Japan
- Prior art keywords
- hydroxyl
- pharmaceutical composition
- neovascular
- alkyl
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2019-0168238 | 2019-12-16 | ||
| KR20190168238 | 2019-12-16 | ||
| PCT/KR2020/018475 WO2021125800A1 (ko) | 2019-12-16 | 2020-12-16 | 신생혈관형성인자의 억제를 위한 화합물 및 그 용도 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023506838A JP2023506838A (ja) | 2023-02-20 |
| JP2023506838A5 true JP2023506838A5 (https=) | 2023-12-20 |
| JP7831775B2 JP7831775B2 (ja) | 2026-03-17 |
Family
ID=76477859
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022536658A Active JP7831775B2 (ja) | 2019-12-16 | 2020-12-16 | 新生血管形成因子を阻害するための化合物およびその用途 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12545695B2 (https=) |
| EP (1) | EP4079309A4 (https=) |
| JP (1) | JP7831775B2 (https=) |
| KR (1) | KR20210076875A (https=) |
| CN (1) | CN114901290B (https=) |
| AU (1) | AU2020409912A1 (https=) |
| BR (1) | BR112022011147A2 (https=) |
| CA (1) | CA3164800A1 (https=) |
| WO (1) | WO2021125800A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114901290B (zh) | 2019-12-16 | 2024-09-03 | 蔚山科学技术院 | 抑制血管新生因子的化合物及其用途 |
| JP7766885B2 (ja) * | 2021-06-15 | 2025-11-11 | スマーティン バイオ インコーポレイテッド | Ｔｒａｐ１阻害剤およびその用途 |
| KR102894216B1 (ko) * | 2022-12-15 | 2025-12-18 | 울산과학기술원 | Trap-1 억제제 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4172896A (en) | 1978-06-05 | 1979-10-30 | Dainippon Pharmaceutical Co., Ltd. | Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same |
| GB9217295D0 (en) | 1992-08-14 | 1992-09-30 | Wellcome Found | Controlled released tablets |
| GB9315856D0 (en) | 1993-07-30 | 1993-09-15 | Wellcome Found | Stabilized pharmaceutical |
| US5358970A (en) | 1993-08-12 | 1994-10-25 | Burroughs Wellcome Co. | Pharmaceutical composition containing bupropion hydrochloride and a stabilizer |
| US5541231A (en) | 1993-07-30 | 1996-07-30 | Glaxo Wellcome Inc. | Stabilized Pharmaceutical |
| DE69839355T2 (de) | 1997-07-29 | 2009-06-04 | Alcon Laboratories, Inc., Fort Worth | Ophthalmische Zusammensetzungen enthaltend Galaktomannanpolymere und Borat |
| AU2483599A (en) | 1998-01-29 | 1999-08-16 | Sepracor, Inc. | Pharmaceutical uses of optically pure (-)-bupropion |
| US20060229278A1 (en) | 1998-11-25 | 2006-10-12 | Antipodean Pharmaceuticals, Inc. | Mitoquinone derivatives used as mitochondrially targeted antioxidants |
| US8889112B2 (en) | 1999-09-16 | 2014-11-18 | Ocularis Pharma, Llc | Ophthalmic formulations including selective alpha 1 antagonists |
| NZ513547A (en) * | 2001-08-13 | 2002-09-27 | Antipodean Biotechnology Ltd | Synthesis of triphenylphosphonium quinols (e.g. mitoquinol) and/or quinones (e.g. mitoquinone) |
| US6933289B2 (en) | 2003-07-01 | 2005-08-23 | Allergan, Inc. | Inhibition of irritating side effects associated with use of a topical ophthalmic medication |
| EP1654002B2 (en) | 2003-08-07 | 2014-01-29 | Allergan, Inc. | Compositions for delivery of therapeutics into the eyes |
| JP4648319B2 (ja) | 2003-08-22 | 2011-03-09 | アンティポディーン ファーマシューティカルズ インコーポレイティド | ミトコンドリアを標的とする抗酸化剤として使用されるミトキノン誘導体 |
| US20050059744A1 (en) | 2003-09-12 | 2005-03-17 | Allergan, Inc. | Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions |
| KR20070030815A (ko) | 2004-07-13 | 2007-03-16 | 오리디스 비오메드 포르슝스-운트 엔트비크룽스 게엠베하 | 간질환 및 상피암의 치료에서 미토콘드리아적으로 표적화된산화방지제의 용도 |
| US7750018B2 (en) | 2006-12-06 | 2010-07-06 | Tactical Therapeutics, Inc | Use of carboxiamidotriazole (CAI) orotate in macular degeneration |
| BRPI1014978A2 (pt) | 2009-04-17 | 2019-07-02 | Colby Pharmaceutical Company | método de tratamento do câncer e composição farmacêutica. |
| KR101621418B1 (ko) | 2014-03-19 | 2016-05-23 | 울산과학기술원 | 미토콘드리아 표적화된 항-종양 조성물 |
| CN114901290B (zh) | 2019-12-16 | 2024-09-03 | 蔚山科学技术院 | 抑制血管新生因子的化合物及其用途 |
-
2020
- 2020-12-16 CN CN202080090674.9A patent/CN114901290B/zh active Active
- 2020-12-16 WO PCT/KR2020/018475 patent/WO2021125800A1/ko not_active Ceased
- 2020-12-16 CA CA3164800A patent/CA3164800A1/en active Pending
- 2020-12-16 JP JP2022536658A patent/JP7831775B2/ja active Active
- 2020-12-16 EP EP20902617.8A patent/EP4079309A4/en active Pending
- 2020-12-16 AU AU2020409912A patent/AU2020409912A1/en not_active Abandoned
- 2020-12-16 BR BR112022011147A patent/BR112022011147A2/pt not_active Application Discontinuation
- 2020-12-16 US US17/784,969 patent/US12545695B2/en active Active
- 2020-12-16 KR KR1020200176125A patent/KR20210076875A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023506838A5 (https=) | ||
| RU2009145939A (ru) | Профилактическое или терапевтическое средство, применяемое при заболеваниях заднего отдела глаза | |
| JP2017514917A5 (https=) | ||
| JP2008538215A5 (https=) | ||
| JP2020530470A5 (https=) | ||
| RU2014123472A (ru) | Производные 4-прегенен-11ss-17-21-триол-3,20-диона для лечения глазных болезней | |
| JP2023509336A5 (https=) | ||
| JP2015025011A5 (https=) | ||
| JP6872322B2 (ja) | クエン酸エステルを含有するデポ剤 | |
| JP2006512318A5 (https=) | ||
| JP2014533274A5 (https=) | ||
| JP2023544716A5 (https=) | ||
| JP2017527600A5 (https=) | ||
| RU2017112930A (ru) | Офтальмологические составы для доставки лекарств и защиты переднего отдела глаза | |
| JP2024041947A (ja) | 眼圧下降増強剤 | |
| JP2013510852A5 (https=) | ||
| KR102266014B1 (ko) | 안질환 예방 또는 치료용 점안 조성물 | |
| JP2010514733A5 (https=) | ||
| WO2008124828A1 (en) | Methods for treating vascular disruption disorders | |
| JP2007527417A5 (https=) | ||
| RU2020119228A (ru) | Соединения, композиции и способы лечения нарушений со стороны органа зрения и заболеваний кожи | |
| RU2012119757A (ru) | 2, 6-диаминопиридиновые соединения для лечения заболеваний, связанных с амилоидными белками, или для лечения глазных болезней | |
| JP2022520832A5 (https=) | ||
| WO2010117077A1 (ja) | シロリムス誘導体を有効成分として含有する網脈絡膜疾患の治療剤 | |
| JP2021138710A5 (https=) |